Results 11 to 20 of about 4,610 (193)

Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307). [PDF]

Support Care Cancer, 2021
Kizub DA, Miao J, Schubert MM, Paterson AHG, Clemons M, Dees EC, Ingle JN, Falkson CI, Barlow WE, Hortobagyi GN, Gralow JR.   +10 more
europepmc   +3 more sources

Systemic immunity shapes the oral microbiome and susceptibility to bisphosphonate-associated osteonecrosis of the jaw. [PDF]

J Transl Med, 2015
Kalyan S, Wang J, Quabius ES, Huck J, Wiltfang J, Baines JF, Kabelitz D.   +6 more
europepmc   +3 more sources

Stress response in periodontal ligament stem cells may contribute to bisphosphonate‑associated osteonecrosis of the jaw: A gene expression array analysis. [PDF]

Mol Med Rep, 2020
Shi Y, Li M, Yu Y, Zhou Y, Zhang W, Hua H, Wang S.   +6 more
europepmc   +3 more sources

Bisphosphonate-associated osteonecrosis of the jaw in rheumatology: a sistematic review

Reumatismo, 2011
Osteonecrosis of the jaw (ONJ) is a well-known devastating side effect of parenteral bisphosphonate therapy for cancer. Several ONJ cases have been reported in patients taking oral bisphosphonates for osteoporosis or Paget’s disease.
F. Capsoni
doaj   +3 more sources

Risk of Osteonecrosis of the Jaw in Patients Treated with Zoledronic or Alendronic Acid: A Systematic Review [PDF]

Medicina
Background and Objectives: Bisphosphonates (BP) like zoledronic acid (ZA) and alendronic acid (AA) are used for osteoporosis (OP) or other bone-related conditions as well as to prevent the spread of metastases and in rheumatoid arthritis treatment ...
Aine Jakonyte, Egle Gustainyte, Zygimantas Petronis, Aviad Hafizov, Audra Janovskiene, Dainius Razukevicius   +5 more
doaj   +2 more sources

Seven Cases of Bisphosphonate-Associated Osteonecrosis of the Jaw

Dental Medicine Research, 2008
Osamu INOUE, Takahiko TOYOSHIMA, Shiho MARUYAMA, Chigusa MOCHIDA, Hitoshi WATANABE, Masaru OHASHI, Tatsuo SHIROTA, Masashi HATORI, Satoru SHINTANI   +8 more
openaire   +3 more sources

Bisphosphonate Associated Osteonecrosis of the Jaw [PDF]

The Journal of Rheumatology, 2009
In 2003, the first reports describing osteonecrosis of the jaw (ONJ) in patients receiving bisphosphonates (BP) were published. These cases occurred in patients with cancer receiving high-dose intravenous BP; however, 5% of the cases were in patients with osteoporosis receiving low-dose bisphosphonate therapy.
Aliya A, Khan, George K B, Sándor, Edward, Dore, Archibald D, Morrison, Mazen, Alsahli, Faizan, Amin, Edmund, Peters, David A, Hanley, Sultan R, Chaudry, Brian, Lentle, David W, Dempster, Francis H, Glorieux, Alan J, Neville, Reena M, Talwar, Cameron M, Clokie, Majd Al, Mardini, Terri, Paul, Sundeep, Khosla, Robert G, Josse, Susan, Sutherland, David K, Lam, Robert P, Carmichael, Nick, Blanas, David, Kendler, Steven, Petak, Louis Georges, Ste-Marie, Jacques, Brown, A Wayne, Evans, Lorena, Rios, Juliet E, Compston   +29 more
openaire   +4 more sources

Evaluation of Jaw Osteonecrosis Following Intra-Ligament Anesthesia in Zoledronate-Treated Rats: a Histological Evaluation [PDF]

Journal of Dentistry, 2023
Statement of the Problem: One of the rare adverse effects in patients who take bisphosphonates is the osteonecrosis of the jaw in the oral cavity following any trauma such as tooth extraction.Purpose: The aim of this study is the histopathological ...
Saeed Moradi, Bibi Marjan Razavi, Siavash Moushekhian, Narges Poormahmood, Mohammad Marvi   +4 more
doaj   +1 more source

Medication-related osteonecrosis of the jaw. Introduction of a new modified experimental model [PDF]

Acta Cirúrgica Brasileira, 2016
PURPOSE : To evaluate a modified experimental model for medication-related osteonecrosis of the jaw (MRONJ) through the upper right central incisor extraction followed by intravenous bisphosphonate administration. METHODS: Forty five rats underwent the
Cláudia Curra, Camila Lopes Cardoso, Osny Ferreira Júnior, Marcos Martins Curi, Mariza Akemi Matsumoto, Bruno Cavalini Cavenago, Pâmela Letícia dos Santos, Joel Ferreira Santiago Júnior   +7 more
doaj   +1 more source

Bisphosphonate-associated osteonecrosis of the jaws

Indian Journal of Dental Research, 2012
Bisphosphonates constitute a group of drugs capable of modulating bone turnover and reduce its remodeling when an excessive resorption occurs. This is why they are indicated in a large group of bone diseases like postmenopausal osteoporosis or osteolysis associated with breast cancer or multiple myeloma.
Rajiv S Desai, Subraj J Shetty
openaire   +6 more sources